Cargando…
Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer
BACKGROUND: In a previous report we have demonstrated that the chymotryptic-like serine protease kallikrein 7 (KLK7/hK7) is overexpressed in pancreatic cancer. In normal skin, hK7 is thought to participate in skin desquamation by contributing in the degradation of desmosomal components, such as desm...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628383/ https://www.ncbi.nlm.nih.gov/pubmed/19091121 http://dx.doi.org/10.1186/1471-2407-8-373 |
_version_ | 1782163691779653632 |
---|---|
author | Ramani, Vishnu C Hennings, Leah Haun, Randy S |
author_facet | Ramani, Vishnu C Hennings, Leah Haun, Randy S |
author_sort | Ramani, Vishnu C |
collection | PubMed |
description | BACKGROUND: In a previous report we have demonstrated that the chymotryptic-like serine protease kallikrein 7 (KLK7/hK7) is overexpressed in pancreatic cancer. In normal skin, hK7 is thought to participate in skin desquamation by contributing in the degradation of desmosomal components, such as desmogleins. Thus, the ability of hK7 to degrade desmogleins was assessed and the effect of hK7 expression on desmoglein 2 was examined in cultured pancreatic cancer cells. METHODS: The expression of Dsg1, Dsg2, and Dsg3 in pancreatic tissues was examined by immunohistochemistry and their expression in two pancreatic cancer cell lines, BxPC-3 and Panc-1, was determined by western blot analysis. The ability of hK7 to degrade Dsg1 and Dsg2 was investigated using in vitro degradation assays. BxPC-3 cells stably transfected to overexpress hK7 were used to examine the effect of hK7 on cell-surface resident Dsg2. RESULTS: The levels of immunoreactive Dsg1 and Dsg2 were reduced in pancreatic adenocarcinomas compared with both normal pancreatic and chronic pancreatitis tissues. Among the desmosomal proteins examined, Dsg2 exhibited robust expression on the surface of BxPC-3 cells. When hK7 was overexpressed in this cell line, there was a significant increase in the amount of soluble Dsg2 released into the culture medium compared with vector-transfected control cells. CONCLUSION: A reduction in the amount of the cell adhesion components Dsg1 and Dsg2 in pancreatic tumors suggests that loss of these desmosomal proteins may play a role in pancreatic cancer invasion. Using in vitro degradation assays, both Dsg1 and Dsg2 could be readily proteolyzed by hK7, which is overexpressed in pancreatic adenocarcinomas. The enforced expression of hK7 in BxPC-3 cells that express significant amounts of Dsg2 resulted in a marked increase in the shedding of soluble Dsg2, which is consistent with the notion that aberrant expression of hK7 in pancreatic tumors may result in diminished cell-cell adhesion and facilitate tumor cell invasion. |
format | Text |
id | pubmed-2628383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26283832009-01-17 Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer Ramani, Vishnu C Hennings, Leah Haun, Randy S BMC Cancer Research Article BACKGROUND: In a previous report we have demonstrated that the chymotryptic-like serine protease kallikrein 7 (KLK7/hK7) is overexpressed in pancreatic cancer. In normal skin, hK7 is thought to participate in skin desquamation by contributing in the degradation of desmosomal components, such as desmogleins. Thus, the ability of hK7 to degrade desmogleins was assessed and the effect of hK7 expression on desmoglein 2 was examined in cultured pancreatic cancer cells. METHODS: The expression of Dsg1, Dsg2, and Dsg3 in pancreatic tissues was examined by immunohistochemistry and their expression in two pancreatic cancer cell lines, BxPC-3 and Panc-1, was determined by western blot analysis. The ability of hK7 to degrade Dsg1 and Dsg2 was investigated using in vitro degradation assays. BxPC-3 cells stably transfected to overexpress hK7 were used to examine the effect of hK7 on cell-surface resident Dsg2. RESULTS: The levels of immunoreactive Dsg1 and Dsg2 were reduced in pancreatic adenocarcinomas compared with both normal pancreatic and chronic pancreatitis tissues. Among the desmosomal proteins examined, Dsg2 exhibited robust expression on the surface of BxPC-3 cells. When hK7 was overexpressed in this cell line, there was a significant increase in the amount of soluble Dsg2 released into the culture medium compared with vector-transfected control cells. CONCLUSION: A reduction in the amount of the cell adhesion components Dsg1 and Dsg2 in pancreatic tumors suggests that loss of these desmosomal proteins may play a role in pancreatic cancer invasion. Using in vitro degradation assays, both Dsg1 and Dsg2 could be readily proteolyzed by hK7, which is overexpressed in pancreatic adenocarcinomas. The enforced expression of hK7 in BxPC-3 cells that express significant amounts of Dsg2 resulted in a marked increase in the shedding of soluble Dsg2, which is consistent with the notion that aberrant expression of hK7 in pancreatic tumors may result in diminished cell-cell adhesion and facilitate tumor cell invasion. BioMed Central 2008-12-17 /pmc/articles/PMC2628383/ /pubmed/19091121 http://dx.doi.org/10.1186/1471-2407-8-373 Text en Copyright © 2008 Ramani et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ramani, Vishnu C Hennings, Leah Haun, Randy S Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer |
title | Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer |
title_full | Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer |
title_fullStr | Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer |
title_full_unstemmed | Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer |
title_short | Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer |
title_sort | desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628383/ https://www.ncbi.nlm.nih.gov/pubmed/19091121 http://dx.doi.org/10.1186/1471-2407-8-373 |
work_keys_str_mv | AT ramanivishnuc desmoglein2isasubstrateofkallikrein7inpancreaticcancer AT henningsleah desmoglein2isasubstrateofkallikrein7inpancreaticcancer AT haunrandys desmoglein2isasubstrateofkallikrein7inpancreaticcancer |